Skip to main content
. 2022 Jul 5;11(14):e023990. doi: 10.1161/JAHA.121.023990

Table 2.

Biomarkers and Echocardiography Variables of the Study Population According to Sex‐Specific FEV1/FVC Ratio Quartiles at ARIC Baseline Visit 5 (n=3476)

FEV1/FVC Quartile 1 Quartile 2 Quartile 3 Quartile 4

Model1

P‐trend

Mode 2

P‐trend

Biomarkers
High‐sensitivity CRP, mg/L 1.7 (0.9–3.7) 1.7([0.8–3.4) 2.0 (1.0–4.3) 1.9 (0.9–4.0) 0.29*
NT‐proBNP, pg/mL 150 (77–272) 127 (70–239) 107 (56–200) 88 (49–168) <0.001* <0.001*
Structure
Mean wall thickness, cm 0.96±0.14 0.97±0.14 0.98±0.13 0.97±0.12 0.14
Relative wall thickness 0.42±0.07 0.42±0.07 0.43±0.07 0.42±0.07 0.67
LV mass index, g/m2 77±19 79±19 77±18 76±16 0.55
LV mass, g 140±42 145±3 145±41 142±36 0.45
LVEDV index, mL/m2 43±10 44±10 43±10 43±10 0.14
Systolic function
LV ejection fraction, % 65.9±5.9 65.9±6.0 66.0±58 66.1±5.7 0.09
Longitudinal strain, % −18.1±2.4 −18.2±2.4 −18.1±2.3 −18.3±2.3 0.15
Stroke volume index, mL/m2 50±15 49±13 47±13 48±16 0.98
Diastolic function
E wave, cm/sec 67±19 66±18 66±17 66±17 0.10
A wave, cm/sec 79±19 78±19 80±18 80±18 0.05
E/A ratio 0.87±0.28 0.87±0.27 0.84±0.26 0.85±0.27 0.004 0.56
Lateral e′, cm/s 7.2±2.1 7.1±2.0 7.1±2.0 7.2±2.0 0.04 0.47
E/e′ lateral 10.1±3.9 9.9±3.6 9.9±3.7 9.7±3.3 0.84
LA volume index, mL/m2 25.5±9.9 26.1±7.9 25.0±8.0 25.1±7.4 0.38
Right ventricle and pulmonary pressure
Estimated PASP, mm Hg 28.2±5.5 27.5±5.1 27.5±5.0 27.3±5.2 0.09
RV fractional area change 0.53±0.08 0.53±0.08 0.52±0.07 0.52±0.07 0.26

Values are expressed as mean±SD or median (25th–75th percentile). Model 1: age, sex, race. Model 2: age, sex, race, current or prior smoking, hypertension, diabetes, atrial fibrillation, body mass index, log high‐sensitivity CRP, log NT‐proBNP. Model 2 analyses were performed only when P<0.05 in model 1. ARIC indicates Atherosclerosis Risk in Communities; CRP, C‐reactive protein; FEV1/FVC, forced expired volume in 1 second and forced vital capacity ratio; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; LA, left atrial; LV, left ventricular; LVEDV, left ventricular end‐diastolic volume; PASP, pulmonary artery systolic pressure; and RV, right ventricular.

*

P value for the log‐transformed CRP and NT‐proBNP trend.